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Abstract 
Effects of drinking a sodium bicarbonated mineral water on cardiovascular risk in young men 
and women with moderate cardiovascular risk were studied. Eighteen young volunteers, total 
cholesterol levels >5.2 mmol/L without any disease participated. The study consisted in two 
8-week intervention periods. Subjects consumed, as a supplement of their usual diet, 1 L/d of 
a control low mineral water followed by 1 L/d of the bicarbonated mineral water (mmol/L: 
sodium, 48; bicarbonate, 35; and chloride, 17). Determinations were performed at the end of 
the control water period and weeks 4 and 8 of the bicarbonated water period. Body weight, 
BMI, blood pressure, dietary intake, total-cholesterol, LDL-cholesterol, HDL-cholesterol, 
Apo A-I, Apo B, triacylgycerols, glucose, insulin, adiponectin, high sensitivity-C reactive 
protein (hs-CRP), soluble adhesion molecules (sICAM and sVCAM), sodium and chloride 
urinary excretion, and urine pH were measured. Dietary intake, body weight and BMI showed 
no significant variations. Systolic blood pressure decreased significantly after 4 weeks of 
bicarbonated water consumption without significant differences between the weeks 4 and 8. 
Significant reductions were observed after bicarbonated water consumption of total 
cholesterol (by 6.3%, p=0.012), LDL-cholesterol (by 10% p=0.001), total/HDL-cholesterol 
(p=0.004), LDL/HDL-cholesterol (p=0.001), and Apo B (p=0.017). Serum triacylglycerols, 
Apo A-I, sICAM-1, sVCAM-1 and hs-CRP levels did not change. Serum glucose values 
tended to decrease during the bicarbonated water intervention (p=0.056) but insulin levels did 
not vary. This sodium bicarbonated mineral water improves lipid profile in moderately 
hypercholesterolemic young men and women and could therefore be applied in dietary 
interventions to reduce cardiovascular risk. 
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1. Introduction 
Intake of electrolytes is important for a variety of biological functions. Sodium, potassium 
through the ATPase system participate in the active transport of many substances and the 
acid-alkaline equilibrium in body fluids is essential for digestive, renal and bone maintenance 
[1, 2]. 
Sodium bicarbonated mineral waters are used in crenotherapy due to their special digestive 
properties. They are recommended to relieve functional dyspepsia and constipation, enhance 
gastric motor and secretory functions, favour the action of pancreatic enzymes and the 
saponifying action of bile, and increase secretion of pancreatic fluids and bile flow [3-7]. A 
salt-rich mineral water consumed during 3 weeks reduced total cholesterol and LDL-
cholesterol, decreased apolipoprotein (Apo) B values, and increased by nearly 100% faecal 
bile acid excretion in hypercholesterolemic subjects that were treated in a crenotherapy 
institution [8]. 
However, results from controlled intervention studies with water assessing dietary intake, 
have not been available until this century. Also recently water was included in food dietary 
reference intake data and in food pyramids [9, 10]. Therefore, the implication of different 
types of water on human metabolic functions and disease prevention is an emerging field. 
Our research group has observed that a mineral water rich in sodium, bicarbonate, and silicon, 
was able to reduce cardiovascular risk in healthy postmenopausal women. It decreased total-
cholesterol, LDL-cholesterol and adhesion molecules (early atherosclerosis markers), 
increased HDL-cholesterol, and reduced fasting plasma glucose [11] and postprandial insulin 
[12]. In addition, it decreased postprandial serum and chylomicron triacylglycerols compared 
with a control mineral water [13]. This mineral water did not alter blood pressure or 
biochemical markers of bone remodelling in postmenopausal women although its sodium 
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content is 1 g/L [11, 14, 15], probably due to the compensating effect of other cations and 
anions in the same water. 
The present study was designed to investigate if the effects on lipoprotein metabolism, 
inflammation biomarkers, and glucose and insulin levels, of a sodium bicarbonated mineral 
water previously observed in postmenopausal women, were confirmed in young moderately 
hypercholesterolemic subjects. 
 
2. Subjects and Methods 
 
The present study was designed and held out following the CONSORT (Consolidated 
Standards of Reporting Trials) statement guidelines [16]. 
 
Subjects 
Volunteers were recruited by different announcements in press, university campus and web 
pages of Madrid. 
Individuals selected for the study had to be young (>18 y and <40 y) men and women and had 
to present total cholesterol levels over 200 mg/dL (5.17 mmol/L), LDL-cholesterol >100 
mg/dL (2.58 mmol/L) to be included in the study. Exclusion criteria were being over 40 y, 
triacylglycerols > 250 mg/dL (2.82 mmol/L) usual consumers of carbonated mineral water, 
obesity, diabetes, hyperthension, or digestive, liver and renal diseases, being under medication 
that could affect lipid metabolism, and consuming functional foods that could affect lipid 
metabolism (foods containing n-3 fatty acids or phytosterols). 
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Forty subjects were initially interested in participating, 37 underwent analytical screening. A 
group of 28 volunteers (19 women and 9 men) were selected. Out of the 28 volunteers, 8 left 
the intervention during the first half of the study and 2 were excluded as they pursued a 
hypocaloric diet during the intervention. Consequently, data analyzed in this research 
correspond to the 18 volunteers (10 women and 8 men) who finished the 16 week trial.  
The participants were instructed not to deviate from their regular habits, to maintain their 
normal diet and body weight and exercise level. 
The study protocols were approved by the Ethics Committee of the National Spanish 
Research Council (CSIC) and the Clinical Research Ethics Committee of Hospital Clínica 
Puerta de Hierro, Madrid 
 
Study design 
The study consisted of 2 consecutive 8-week intervention periods during the cold season. 
Subjects consumed, as a supplement of their usual diet, 1 L/d of a control low mineral water 
during the first period and 1 L/d of a carbonic sodium bicarbonated mineral water during the 
second period. The experimental periods were as previously assayed [11] with repeated 
measurements after 4 weeks and 8 weeks of bicarbonated water consumption. Both mineral 
waters were provided in 0.5-L bottles by Vichy Catalán, S.A. without any label that could 
indicate their composition. It was not possible to elaborate bicarbonated placebo water; 
therefore the study compares the effects of two different commercial mineral waters. The 
bicarbonated mineral water was rich in bicarbonate, sodium, and chloride, whereas the control 
water was low in minerals (Table 1). 
Mineral water compliance and possible variations in dietary habits were monitored with 
 6
specific food intake questionnaires. Each subject’s dietary intake was evaluated monthly to 
control possible changes in lipid metabolism associated with modifications in dietary intake. 
Once per month they completed a 72-hour detailed dietary intake report, specifying the types 
of food consumed and serving weights. Dietary intake forms were previously validated and 
proved valuable to assess intake changes related to lipid and glucose metabolism [17]. Dietary 
food, energy, nutrient intakes, and energy provided by macronutrients were calculated by an 
informatic application using Spanish Food Composition Database [18]. Cholesterol, food 
phytosterols and fibre intakes were also assessed. 
Body weight was measured without shoes and with light clothing with a Seca scale (to a 
precision of ±100 g), and height with a stadiometer incorporated with the scale  and BMI was 
calculated. Systolic and diastolic blood pressure was measured with a validated digital 
automated blood pressure monitor (OMROM M6, Omrom Health Care Co., Ltd, Kyoto, 
Japan), and waist circumference were monitored monthly by trained personnel. At baseline 
and at the end of the control water period and weeks 4 and 8 of the bicarbonated water period, 
blood samples were taken for analytical determinations.                                                                                     
 
Biochemical determinations in blood  
Blood samples were collected by venipuncture between 0800 and 0830 h, after a 12-h fasting 
period. The volunteers followed written instructions regarding dinner composition the 
evening before the analysis (lettuce and tomato with olive oil, vinegar and salt, grilled chicken 
fillet, bread and fruit). Serum was separated by low-speed centrifugation for 15 min. Serum 
total cholesterol, HDL-cholesterol, and triacylglycerol (TAG) concentrations were measured 
by automated enzymatic methods (CHOD-PAP and GPO-PAP, Boehringer Mannheim, 
Germany; and RA-XT autoanalyzer, Technicon, Tarrytown, NY, USA). Serum LDL-
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cholesterol concentration was calculated using the Friedewald formula [19]. The 
cardiovascular (CVD) risk indexes were calculated as total cholesterol/HDL-cholesterol and 
LDL-cholesterol/HDL-cholesterol ratios.  
Soluble intercellular adhesion molecules (sICAM-1) and soluble vascular adhesion molecules 
(sVCAM-1) of serum stored at -80°C were measured by ELISA using commercially available 
kits (Parameter, R&D Systems, Minneapolis, Minnesota, USA). High sensitive C-reactive 
protein (hs-CRP) was determined also by ELISA (DRG International, Mountainside, New 
Jersey, USA). 
Apo A-I and Apo B were determined at baseline and at the end of the two water periods by 
turbidimetry (Behring Turbitimer, Barcelona, Spain) using Dade Behring reactives and 
protocols. 
Fasting serum glucose concentrations were analyzed by an automatic analyzer (RA 2000, 
Technicon, USA). Serum insulin levels were determined by means of an immunometric assay 
in an autoanalyzer (Immulite® 2000 Insulin, Diagnostic Products Corporation-DPC, UK), 
and adiponectin by ELISA (MDT-E09, Mediagnost, Reutlingen, Germany). 
At the end of both intervention periods, 24 h urine samples were collected. Urine pH was 
measured. Urinary Na+ and Cl- concentrations were determined by electrolyte analyser 
(EMLTM 100 Electrolyte Laboratory; Radiometer Copenhagen, Radiometer Medical A/S, 
Brønshøj, Denmark). Urine samples were diluted 2:1 (urine:diluent) with diluent for urine 
S2490 (Radiometer Copenhagen). Na+ and Cl- were determined in one run. QualitycheckTM 
S2480 and S2470 (Radiometer Copenhagen) were used as internal standards to assess 
precision.  
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Statistics 
Data are presented as means ± SD. The Kolmogorov-Smirnov and the Shapiro-Wilk tests 
were used to determine variable distribution. TAG values were log transformed before 
statistical analysis. Data were analyzed by ANOVA with repeated measures and post-hoc 
Bonferroni test. Values of P < 0.05 were considered significant. The SPSS statistical package 
for Windows (version 15.0) was used to analyze the data. 
 
3. Results 
Eighteen volunteers completed the study, their basal characteristics are shown in Table 2. 
Compliance rate was confirmed by dietary reports and questionnaires about the number of 
water bottles that were consumed and how many were left over. Dietary energy intake of the 
volunteers who participated in the study did not show any variation during the study period 
(Table 3). There were no changes in protein, carbohydrate, fat, cholesterol, plant phytosterols 
and fibre intakes and the type of fat ingested did not differ between the two intervention 
periods. 
Body weight, BMI and waist circumference remained constant (Table 4). Systolic blood 
pressure decreased significantly after drinking bicarbonated mineral water during 4 weeks 
(p=0.023), without significant differences between the 4th and the 8th weeks. Diastolic blood 
pressure remained unchanged during the whole study.  
Total serum cholesterol and LDL-cholesterol were significantly lower after 8 weeks of 
bicarbonated water consumption than after the control water period (p=0.012 and p=0.001, 
respectively) (Table 5), without significant differences between the weeks 4 and 8 of 
bicarbonated water consumption. HDL-cholesterol increased marginally although the change 
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was not significant (p=0.085). Serum TAG levels did not show significant differences due to 
the water consumption. The CVD risk indexes, total cholesterol/HDL-cholesterol and LDL-
cholesterol/HDL-cholesterol, showed a significant decrease during the bicarbonated mineral 
water consumption (p=0.004 and p=0.001, respectively). The differences between the week 4 
and week were not significant for the first index while for the second a significant reduction 
was observed at week 8 compared to week 4.  
Apo A-I levels did not change while Apo B concentrations decreased during the bicarbonated 
mineral water period (p=0.017). The HDL/Apo A-I and LDL/Apo-B ratios remained stable 
during the two water periods. sICAM-1, sVCAM-1 and hs-CRP levels did not change. Serum 
glucose values tended to decrease during the consumption of bicarbonated mineral water but 
the values did not reach statistical significance (p=0.056) and insulin levels did not 
significantly decrease between the two water intervention periods.  
Urinary pH was significantly higher after the bicarbonated mineral water period than the 
control water period (mean±SD: 6.43±0.50 and 7.01±0.37 respectively, p= 0.001). Na+ and 
Cl- concentrations (mean±SD, mmol/L) increased significantly during the bicarbonated 
mineral water period (Na+, 80.2±33.9 vs 118.9±56.1, p=0.003; and Cl- , 98.9±31.9 vs 
128.0±55.2, p=0.023, for the control and bicarbonated water respectively).  
 
4. Discussion 
This study shows that consuming 1 L/day of a bicarbonated sodium rich mineral water 
reduces total-cholesterol (by 6.3%), LDL-cholesterol (by 10%), Apo B, and CVD risk 
indexes, as well as systolic blood pressure in young moderately hypercholesterolemic 
subjects.  
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In agreement, a salt-rich mineral water reduced total cholesterol, LDL-cholesterol, and 
decreased Apo B values in hypercholesterolemic subjects [8]. Previous findings using the 
same mineral water of the present study showed a reduction in total and LDL-cholesterol and 
an increase in HDL-cholesterol in postmenopausal women after 8 weeks [11]. Present results 
show that 4 weeks is not enough to observe significant lipid changes in these moderately 
hypercholesterolemic subjects while at 8 week a clear effect was observed.  
Mean LDL-cholesterol values decreased from 3.77 to 3.40 mmol/L, which means a change 
from ‘borderline high’ to ‘near or above optimal’ levels [20]. Our previous observations in 
postmenopausal women showed that a 15% reduction in LDL-cholesterol due to the 
bicarbonated water consumption significantly reduced cardiovascular risk and the estimated 
10-y risk of coronary heart disease [11]. It has been stated that decreasing LDL-cholesterol by 
10-15% might involve a 25% risk reduction for coronary heart disease [21] and that lowering 
of circulating LDL-cholesterol levels in patients with chronic coronary artery disease is 
associated with a retarded progression of atherosclerosis as well as a decrease of 
cardiovascular events and lower mortality [22]. Moreover, mortality from coronary heart 
disease increases exponentially as a function of serum cholesterol levels [23],  
The proposed mechanisms are related with the moderate alkaline nature of the study mineral 
water and an osmotic effect that may influence fat and cholesterol absorption and/or increase 
bile acid excretion. 
It is known that the rate of fatty acid and cholesterol absorption from the micellar solution 
formed in the small intestine is favoured by a lower pH [24-26] and that pancreatic enzymes 
and bile salts action is enhanced by increasing pH. Therefore, an increase in luminal pH 
induced by the study water may decrease absorption of both cholesterol and fat. Consistently, 
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this mineral water increased urinary pH in the young volunteers of the present study and in 
postmenopausal women [14] and reduced postprandial lipaemia [13]. 
Different mineral waters are able to increase bile excretion either consumed with or without 
meal [7]. Capurso et al. [8] found that consumption of a carbonated mineral water with higher 
electrolyte concentration than the study water (sodium, 5535 mg/L and chloride, 922 mg/L) 
during 3 weeks increased faecal bile acid excretion by nearly 100% and reduced gallbladder 
volume by 40%. Marchi et al. [27] studied cholecystic volume after ingestion of only mineral 
water rich in bicarbonate (777 mg/L), calcium (231 mg/L), and sulphate (166 mg/L), which 
contained moderate quantities of sodium (103 mg/L) and chloride (119 mg/L), compared to 
physiologic solution, and found that cholecystic volume was reduced 10 to 60 min after 
ingestion. Other authors also observed reductions of gallbladder volume using mineral waters 
rich in sulphate and calcium [28, 29], bicarbonate and calcium [30], and sulphate and 
bicarbonate [31]. Cholecystokinin is the main responsible but duodenal mucosa contains 
many receptors sensitive to pH, lipid composition, osmolality, etc. Fiorucci et al. [32] tested 
the effects of increasing concentrations of NaCl solutions and found that a significant 
reduction on gallbladder volume was obtained when hyperosmolar saline was delivered into 
the duodenum. Emptying was not produced when the solution was infused into the gastric 
antrum or the illeum. Therefore, it is possible that mineral waters with very different ionic 
composition exert all an influence stimulating biliar flow into the duodenum due to their high 
osmolality. In fact, laxative waters generally contain a high ionic concentration [8]. 
The mechanisms by which this mineral water lowers serum total and LDL-cholesterol could 
resemble those of soluble fibre. Many published reports present the regulation of cholesterol 
metabolism in response to dietary fibre consumption. Soluble fibre reduces cholesterol 
absorption, mainly due to viscosity, and also interferes with enterohepatic circulation of bile 
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acids, both are believed to alter cholesterol homeostasis by two related mechanisms: a 
decrease in the delivery of dietary cholesterol to the liver through chylomicron remnants 
results in direct reduction in the hepatic cholesterol pool, and an increase in the faecal loss of 
bile acids may stimulate the liver to produce more bile acids from cholesterol [33-36]. 
Consequently, hepatic receptors of LDL increase and serum LDL-cholesterol declines. 
Consumption of soluble fibre has been associated with increased hepatic LDL receptor 
expression, reduction in hepatic Apo B secretion, and decreased numbers of intermediate 
density lipoproteins (IDL) and LDL [37]. Phytosterols alone or in combination with soluble 
fibre exert similar effects [21, 37]. 
Another resemblance comes from hypocholesterolemic drugs such as cholestyramine that are 
also typical bile acid sequestrants. They act as ionic-exchange resins rich in ammonium 
groups that are considered basic because they exchange the negatively charged hydroxide ions 
from bile acids. Therefore, the present results could be explained by choleretic (stimulation of 
bile production) and cholagogue (stimulation of gallbladder contraction) properties of the 
study water which may involve a reduction of the size of the bile acid pool and increased 
conversion rate of cholesterol into bile acid, lowering total cholesterol and LDL-cholesterol 
levels. Malabsorption of bile acid leads to a fall in LDL-cholesterol and a tendency to increase 
HDL-cholesterol [38] without changes in serum TG [39]. We raise the hypothesis that the 
weakly alkaline mineral water used in the present assay may exert a similar influence on bile 
acids and consequently on circulating cholesterol levels. 
The slight increase in HDL-cholesterol observed in the present study is in agreement with the 
previous significant increase observed in postmenopausal women [11] and to the reduction in 
postprandial lipaemia also reported in postmenopausal women after consuming a meal 
together with this sodium bicarbonated water [13].  HDLs provide a vehicle for unesterified 
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cholesterol elimination in bile that is consistent with their putative function in reverse 
cholesterol transport. Therefore, the hypothesis that liver cholesterol is diverted for bile acid 
synthesis is supported by an increase in HDL-cholesterol levels. 
The decrease of both LDL-cholesterol and Apo B levels shown in the present study, and no 
variation in the LDL-cholesterol/Apo B ratio, suggests that LDL size is unchanged but there 
is a lower number of circulating LDL particles [21, 40]. Therefore, it is possible that 
expression LDL receptors increased in liver to compensate the decrease in cholesterol pool as 
a consequence of bile acid sequestration and enhanced bile production. This LDL results are 
relevant because it is known that an increase in the number of small and dense LDL particles 
increases atherogenesis risk [40].   
Our postprandial lipaemia study published before showed that after consuming the sodium 
bicarbonate mineral water with a fat-rich meal, the concentrations of chylomicron 
triacylglycerols decreased during digestion, and chylomicron cholesterol tended to decreased, 
which is associated with lower CVD risk [13]. Therefore, it appears that the study mineral 
water alters fat and cholesterol absorption. 
We also determined inflammation biomarkers, hsCRP, two markers of endothelial 
dysfunction and adiponectin. In contrast to previous results obtained in postmenopausal 
women [11], adhesion molecules sICAM and sVCAM did not change. These soluble forms 
are related to age and diet. Unexpectedly, sVCAM values are higher in the present study than 
in the previous one. This can be explained because young subjects’ usual diet was higher in 
percentage of energy supplied from fat and did not conform with the fruit and vegetable 
dietary recommendations compared with the postmenopausal women, as it has been suggested 
that sVCAM reflects diet more than sICAM [41]. 
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Body weight did not vary during the whole intervention, which suggests that the effects of the 
test water are cholesterol specific and does not alter total body fat. Adiponectin, a hormone 
secreted by the adipocytes that exerts anti-inflammatory and insulin sensitizing properties, 
was unchanged after consuming the bicarbonated mineral water. Nevertheless, in agreement 
with previous observations suggesting insulin sensitivity enhancement [11, 12], a tendency to 
lower glucose and insulin levels was obtained after consumption of this water in the present 
study, although the young volunteers were normoglycaemic and presented low risk of insulin 
resistance. 
The present investigation shows a significant reduction of systolic blood pressure after 4 
weeks of consumption of the bicarbonated mineral water, within normal limits, in young 
dislipaemic subjects. Drinking this bicarbonated mineral water induced aldosterone decrease 
after 2 h of consumption and did not affect blood pressure in normotensive postmenopausal 
women after 8 weeks of consumption of the same amount as in the present study (1L/day) 
[11, 15]. The electrolyte urinary excretion, which shows elevated sodium and chloride 
concentration after the bicarbonated water consumption, suggests that the kidney is able to 
eliminate extra salt and protect the young volunteers against hypertension. This is supported 
by our previous observations [15].   
Significant reductions of systolic blood pressure have been obtained in hypertensive 
individuals treated with 3 L/day of a NaHCO3- containing water (26.2 mmol/l sodium and 
33.0 mmol/l HCO3) compared to a control solution of equimolar amounts of cations as the 
chloride salt for 7 days (total daily sodium 138 mmol) [42]. It has been demonstrated in three 
experimental rat models: Dahl salt-sensitive rat, deoxycorticosterone acetate-salt rat (DOCA-
salt rat) and spontaneously hypertensive rat, that NaCl-dependent hypertension requires the 
provision of high dietary intake of both sodium and chloride [43]. Later studies confirmed in 
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DOCA-salt rats that Na+ without Cl- is unable to increase blood pressure, thus NaCl increases 
blood pressure while NaHCO3 and KHCO3 do not [44]. Extracellular fluid volume 
enlargement and plasma volume expansion play a key role in the pathogenesis of 
hypertension induced by high salt intake. Sodium chloride increases extracellular volume 
compared with non-chloride sodium salts. In addition, chloride itself may act as a direct 
vasoconstrictor [43, 45].  
These reports are in accordance with the present results and explain that, although the 
bicarbonated mineral water supplied 1 g Na+ per day, it did not increase blood pressure and 
even reduced systolic blood pressure, because it also supplied 2 g of HCO3- and only 0.5 g of 
Cl-. 
To appropriately interpret these findings it should be considered that the young volunteers 
were healthy and selected without renal disease, therefore they were able to excrete the extra 
sodium chloride that was ingested in the form of bicarbonated mineral water. 
Finally, it is important to note that these subjects were not on a low fat diet and consumed the 
mineral water as a supplement to their usual diet and beverages. SFA intake was quite high, 
13% of total energy intake, instead of < 7% proposed by AHA [20] and the Spanish CEIPC 
[46], while MUFA intake (20% of total energy intake) was approaching “Mediterranean diet” 
values. The effects of this bicarbonated mineral water on subjects under low fat diets or under 
lipid-lowering medication are not known, although we observed in previous studies in 
postmenopausal women who ingested less fat in their usual diet, that this mineral water 
presented a clear LDL-reducing effect. 
Further studies should be designed on the mechanism involved in relation to cholesterol 
absorption and synthesis. Because hepatic bile acid synthesis is a crucial step in the 
maintenance of cholesterol homeostasis, determination of circulating levels of metabolic 
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precursors of bile acid synthesis or the limiting enzyme 7-α hydroxilase activity, should be 
carried out. A later step would be to study the possible application of this mineral water as a 
part of a low fat diet in cardiovascular disease patients. 
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Table 1 
Mineral composition of the mineral waters employed in the study  
 
 Control Water Carbonated water* 
 mg/L (mmol/L) 
HCO3- 104 (1.70) 2120  (34.75) 
Cl- 11 (0.31) 597 (16.84) 
SO42- 15.6 (0.16) 45.3 (0.47) 
F- <0.2 (<0.01) 0.9 (0.05) 
Ca2+ 33.4 (0.83) 32.0 (0.80) 
Mg2+ 5.0 (0.20) 9.4 (0.39) 
Na+ 8.7 (0.38) 1102 (47.91) 
K+ 2.0 (0.05) 49.5 (1.27) 
 
* Contains 3.9 g/L of CO2 
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Table 2 
Baseline values of the study participants  
 Baseline values 
Age (y) 29±8 
Weight (kg) 71.1±18.5 
BMI (kg/m2) 24.38±4.24 
Waist (cm) 81.83±15.14 
Systolic blood pressure (mmHg) 116.1±11.9 
Diastolic blood pressure (mmHg) 74.3±11.4 
Total Cholesterol (mmol/L) 5.71±0.82 
Triacylglycerols (mmol/L) 1.19±0.64 
HDL-cholesterol (mmol/L) 1.57±0.40 
LDL-cholesterol (mmol/L) 3.69±0.73 
Total/HDL-cholesterol 3.9±1.3 
LDL/HDL-cholesterol 2.6±1.1 
Apo A-I (g/L) 2.21±0.40 
Apo B (g/L) 1.18±0.47 
HDL/Apo A-I 0.30±0.10 
LDL/Apo B 1.36±0.46 
Glucose (mmol/L) 4.79±0.39 
Insulin (mU/L) 8.8±4.1 
Adiponectin (µg/ml) 9.12±6.08 
s-ICAM-1 (µg/L) 265.8±73.4 
sVCAM-1 (µg/L) 576.1±176.3 
hs-CRP (µg/ml) 0.79±0.55 
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Values are mean±SD
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Table 3  
Energy, nutrient, fibre, cholesterol, and plant phytosterols intake of the study participants during the study 
 Control water Bicarbonated water 1st month Bicarbonated water 2nd month 
Energy (kcal/day) 2436±119 2389±149 2475±167 
Carbohydrate (g/d) 226.3±13.5 212.9±13.0 216.3±14.8 
Protein (g/d) 89.9±3.9 88.0±5.9 84.6±4.8 
Lipid (g/d) 116.1±6.3 114.5±8.1 118.9±8.9 
SFA (g/d) 37.03±2.40 36.04±2.48 37.50±2.98 
MUFA (g/d) 52.98±3.04 53.37±4.13 56.54±4.26 
PUFA (g/d) 17.21±2.34 15.90±2.10 15.68±1.92 
PUFA n-6 (g/d) 3.66±0.48 4.87±0.87 4.10±0.37 
PUFA n-3 (g/d) 0.29±0.03 0.36±0.05 0.36±0.03 
Cholesterol (mg/d) 337.8±29.2 327.0±27.8 350.5±33.2 
Carbohydrate (% energy) 34.8±2.1 33.4±2.0 32.8±2.2 
Protein (% energy) 14.8±0.6 14.7±1.0 13.7±0.8 
Lipid (% energy) 42.9±2.3 43.1±3.0 43.2±3.3 
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SFA (% energy) 13.7±0.9 13.6±0.9 13.6±1.1 
MUFA (% energy) 19.6±1.1 20.1±1.6 20.6±1.5 
PUFA (% energy) 6.4±0.9 6.0±0.8 5.7±0.7 
Food Phytosterol (mg/d) 47.3±8.7 51.2±11.0 37.6±7.6 
Fibre (g/d) 32.9±3.0 30.0±2.9 30.9±3.4 
 
Values are mean±SD. Differences between waters and sampling points were not significant.
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Table 4 
Anthropometric and blood pressure data of the volunteers 
 Control water Bicarbonated water 1st month Bicarbonated water 2nd month ANOVA 
Weight (kg) 70.9±18.1 71.2±17.9 70.9±17.9 NS 
BMI (kg/m2) 24.3±4.1 24.4±4.0 24.3±4.1 NS 
Waist circumference (cm) 81.3±15.4 80.9±15.3 80.9±15.4 NS 
Systolic blood pressure (mmHg) 120±19a 111±14b 115±18ªb 0.023 
Diastolic blood pressure (mmHg) 71±12 68±10 72±11 NS 
 
Values are mean ± SD. ANOVA of repeated measures. Within the same row different letters indicate significant differences by the Bonferroni test 
(p<0.05) 
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Table 5  
Serum lipids, adhesion molecules, glucose, insulin, adiponectin, high-sensitivity C- reactive protein and CVD risk indexes of the subjects who 
consumed control and bicarbonated water for 2 months each. 
 Control water Bicarbonated water 1st month Bicarbonated water 2nd month ANOVA 
Total Cholesterol (mmol/L) 5.78±0.73a 5.45±0.91ab 5.42±0.67b 0.012 
Triglycerides (mmol/L) 1.30±0.65 1.21±0.57 1.20±0.57 NS 
HDL-cholesterol (mmol/L) 1.51±0.31 1.49±0.32 1.56±0.33 NS (0.085) 
LDL-cholesterol (mmol/L) 3.77±0.69ª 3.52±0.84ab 3.40±0.67b 0.001 
VLDL-cholesterol (mmol/L) 0.59±0.30 0.55±0.26 0.55±0.26 NS 
Total/HDL-cholesterol  4.0±1.07a 3.8±1.11ab 3.7±1.08b 0.004 
LDL/HDL-cholesterol 2.6±0.8a 2.5±0.9a 2.3±0.9b 0.001 
Apo A-I (g/L) 2.20±0.35 - 2.08±0.35 NS 
Apo B (g/L) 1.35±0.41ª - 1.07±0.21b 0.017 
HDL/Apo A-I 0.28±0.07 - 0.30±0.04 NS 
LDL/Apo B 1.15±0.43 - 1.25±0.99 NS 
Glucose (mmol/L) 4.85±0.43 4.62±0.35 4.65±0.31 NS (0.056) 
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Insulin (mU/L) 8.2±2.6 - 7.7±4.3 NS 
Adiponectin (µg/ml) 11.59±8.10 12.69±8.65 10.67±8.40 NS 
s-ICAM-1 (µg/L) 265.8±73.4 238.4±37.1 238.3±58.7 NS 
sVCAM-1 (µg/L) 576.1±176.3 614.2±168.6 594.0±163.8 NS 
hs-CRP (µg/ml) 0.94±0.94 1.49±2.53 2.07±3.47 NS 
 
hs-CRP: High-sensitivity C- reactive protein; s-ICAM-1, serum intercellular adhesion molecules;  sVCAM-1, serum vascular adhesion molecules. 
Values are mean± SD. ANOVA of repeated measures. Within the same row different letters indicate significant differences by the Bonferroni test 
(p<0.05)  
 
